INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 92 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,871,000 | +50.8% | 228,700 | -23.8% | 0.55% | +3.6% |
| Q2 2019 | $3,894,000 | +6.6% | 300,000 | 0.0% | 0.53% | +59.6% |
| Q1 2019 | $3,654,000 | +40.4% | 300,000 | +519.8% | 0.33% | -12.3% |
| Q4 2015 | $2,603,000 | -38.3% | 48,400 | -54.1% | 0.38% | -29.2% |
| Q3 2015 | $4,220,000 | +3.2% | 105,400 | -17.7% | 0.54% | +34.2% |
| Q2 2015 | $4,090,000 | +14.2% | 128,000 | -14.7% | 0.40% | +7.5% |
| Q1 2015 | $3,582,000 | +125.3% | 150,000 | +59.1% | 0.37% | -4.8% |
| Q2 2014 | $1,590,000 | -12.5% | 94,300 | -5.7% | 0.39% | -5.5% |
| Q1 2014 | $1,818,000 | – | 100,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |